Drug Approval | July 26, 2023
NATCO files generic Erdafitinib Tablets in USA
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
All claims against the company in the litigation have now been dismissed.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
